<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We recently reported increased <z:chebi fb="0" ids="16393">sphingosine</z:chebi> kinase 1 (SPHK1) and decreased neutral sphingomyelinase 2 (NSMase2) gene expression in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> and <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>This alteration is supposed to change the cellular <z:chebi fb="0" ids="26739">sphingolipid</z:chebi> metabolites; however, positive correlations were observed between <z:chebi fb="0" ids="41977">daunorubicin</z:chebi> (<z:mp ids='MP_0000273'>DA</z:mp>)-IC50 and the SPHK1 message but not between <z:mp ids='MP_0000273'>DA</z:mp>-IC50 and NSMase2 messages, when 16 different <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell lines were used to analyze the relationship between gene expressions and chemosensitivity against <z:mp ids='MP_0000273'>DA</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Using two cell lines with either the highest or lowest SPHK1 expression, cellular <z:chebi fb="7" ids="17761">ceramides</z:chebi> and <z:chebi fb="0" ids="37550">sphingosine 1-phosphate</z:chebi> (S1P) were quantified by liquid chromatography/mass spectrometry </plain></SENT>
<SENT sid="3" pm="."><plain>Increased <z:chebi fb="7" ids="17761">ceramide</z:chebi> was observed in <z:mp ids='MP_0000273'>DA</z:mp>-sensitive, but not in <z:mp ids='MP_0000273'>DA</z:mp>-resistant cell lines treated with low doses of <z:mp ids='MP_0000273'>DA</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Upon <z:mp ids='MP_0000273'>DA</z:mp> treatment, S1P decreased more in the sensitive cell lines than in resistant cell lines </plain></SENT>
<SENT sid="5" pm="."><plain>A SPHK inhibitor recovered the <z:mp ids='MP_0000273'>DA</z:mp> sensitivity of <z:mp ids='MP_0000273'>DA</z:mp>-resistant cells </plain></SENT>
<SENT sid="6" pm="."><plain>The modulation of SPHK1 gene expression by either overexpression or using siRNA affected the <z:mp ids='MP_0000273'>DA</z:mp> sensitivity of representative cell lines </plain></SENT>
<SENT sid="7" pm="."><plain>Results clearly show that SPHK1 is both a good marker to predict the <z:mp ids='MP_0000273'>DA</z:mp> sensitivity of <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells and a potential therapeutic target for <z:hpo ids='HP_0001909'>leukemia</z:hpo> with high SPHK1 expression, and suggest that the <z:chebi fb="0" ids="26739">sphingolipid</z:chebi> rheostat plays a significant role in <z:mp ids='MP_0000273'>DA</z:mp>-induced cytotoxicity </plain></SENT>
</text></document>